Clinical and cost-effectiveness of diagnostic strategies incorporating Beta-D-glucan (BDG) tests to reduce unnecessary use of empirical antifungal therapies for invasive Candida infection in the critical care setting.
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
"This plain language summary has been produced based on SHTG advice statement 02/19 (Jan 2019)".
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 25 June, 2019)
Candidiasis
Nosocomial infections